Cocrystal Pharma's total assets for Q1 2025 were $10.66M, a decrease of -20.79% from the previous quarter. COCP total liabilities were $1.42M for the fiscal quarter, a -63.79% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.